WO2023212931A1 - Composition for brightening or toning the skin - Google Patents
Composition for brightening or toning the skin Download PDFInfo
- Publication number
- WO2023212931A1 WO2023212931A1 PCT/CN2022/091214 CN2022091214W WO2023212931A1 WO 2023212931 A1 WO2023212931 A1 WO 2023212931A1 CN 2022091214 W CN2022091214 W CN 2022091214W WO 2023212931 A1 WO2023212931 A1 WO 2023212931A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- amps
- acrylic acid
- polymer
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
Definitions
- the present invention relates to a cosmetic composition.
- the present invention relates to a composition for brightening or toning the skin, in particular human skin.
- the colour of human skin colour depends on various factors, and in particular on the seasons of the year, on race and on gender; it is mainly determined by the nature and the concentration of melanin produced by melanocytes.
- Melanocytes are specialized cells which synthesize melanin by means of specific organelles, melanosomes.
- certain individuals experience the appearance of dark and/or coloured spots on the skin and more especially on the hands, which give the skin heterogeneity.
- compositions for caring for and/or making up keratin materials, in particular the skin are usually in the form of an emulsion of the oil-in-water (O/W) type consisting of an aqueous dispersing continuous phase and an oily dispersed discontinuous phase, or of an emulsion of the water-in-oil (W/O) type consisting of an oily dispersing continuous phase and an aqueous dispersed discontinuous phase.
- O/W oil-in-water
- W/O water-in-oil
- O/W emulsions are the ones most sought in the cosmetics field, since they comprise an aqueous phase as the external phase, which gives them, when applied to the skin, a fresher, less greasy and lighter feel than W/O emulsions.
- the conventional oil-in-water emulsions are not totally satisfying, in particular in terms of brightening or toning of the skin.
- the product for brightening or toning the skin has a suitable viscosity so that there are no droplets falling from the consumer’s hand and it is not difficult to apply the product when the product is applied on the skin.
- compositions for brightening or toning the skin which can provide brightening or toning effect on the skin, and which has suitable viscosity and is stable.
- An object of the present invention is to provide a composition for brightening or toning the skin, which can provide brightening or toning effect on the skin, and which has suitable viscosity and is stable.
- Another object of the present invention is to provide a cosmetic process for brightening or toning the skin.
- the present invention provides a composition for brightening or toning the skin in the form of a gel, comprising, in a hydrophilic phase,
- APMS 2-acrylamido-2-methylpropanesulfonic acid
- the composition according to the present invention has a brightening or toning effect to the skin, in particular human skin.
- the composition according to the present invention has a viscosity of from 4500 to 16000 mpa.s as determined with a Rheomat 100 Plus viscometer equipped with a spindle M4 at 25°C, so that there are no droplets falling from the consumer’s hand and it is not difficult to apply the composition when the composition is applied on the skin.
- composition according to the present invention is stable over time.
- the present invention provides a cosmetic process for brightening or toning the skin, comprising applying the composition as defined above to the skin.
- keratin material is intended to cover human skin.
- Human skin in particular skin of face, neck, back and hand is most particularly considered according to the present invention.
- composition in the form of a gel according to the present invention comprising, in a hydrophilic phase,
- APMS 2-acrylamido-2-methylpropanesulfonic acid
- the cosmetic composition according to the present invention comprises at least one white particles.
- white is intended to mean particles having the colour white and its derivatives (off-white, alabaster white, etc. ) , as opposed to primary colours and derivatives.
- the white particles used are inorganic particles.
- the white particles have a lightness value L*close to 100 in the CIELab76 system.
- the white particles is characterized by 0.3 ⁇ m ⁇ D50 ⁇ 40 ⁇ m.
- the volume average size (D50) is a parameter for particle size distribution, referring to the maximum particle diameter below which 50%of the sample volume exists (see in “A Basic Guide To Particle Characterization” , page 10, published by Malvern Instruments Limited in 2012) .
- the volume average size (D50) of the particles may be measured by static light scattering using a commercial granulometer such as the MasterSizer 3000 machine from Malvern.
- the data are processed on the basis of the Mie scattering theory.
- This theory which is exact for isotropic particles, makes it possible to determine, in the case of non-spherical particles, an "effective" particle diameter. This theory is especially described in the publication by Van de Hulst, H.C., "Light Scattering by Small Particles, " Chapters 9 and 10, Wiley, New York, 1957.
- the white particles according to the present invention have a continuous effect, which is controlled by the resolution capacity of the eye. Since said capacity is around 40 ⁇ m, particles having a volume average size (D50) of less than 40 ⁇ m, preferably less than 25 ⁇ m and even better still less than or equal to 6 ⁇ m are therefore considered. However, it is ensured that particles of which the D50 is greater than 0.3 ⁇ m and preferentially 0.5 ⁇ m are taken, so as not to have too great a loss of opacity, which would be extremely detrimental to the desired effect.
- D50 volume average size
- composition of the present invention preferably comprises at least white particles having a volume size (D50) of less than 40 ⁇ m, preferably between 0.3 and 25 ⁇ m and better still between 0.3 and 6 ⁇ m, or even between 0.5 and 3 ⁇ m.
- D50 volume size
- These particles may be made of one material or else be composites.
- these particles may be selected from boron nitride, silica, pearl, mica, synthetic mica, mica based pearl pigment particles, composite particles comprising titanium dioxide and a substrate selected from alumina, silica, barium sulfate, glass, mica and synthetic mica, or mixtures thereof.
- the particles are boron nitride particles.
- the particles are composite particles comprising titanium dioxide and an alumina substrate.
- the particles are composite particles comprising titanium dioxide and a mica substrate.
- the white particles are advantageously boron nitride particles, preferentially having a volume average size of from 0.3 to 6 ⁇ m.
- the white particles according to the present invention have an average refractive index of between 1.4 and 2.2. This is because, if the particle has a refractive index above 2.2, the opacity of the composition is too high, and if this index is below 1.4, the lightening effect is not sufficient.
- the average refractive index is defined as being the sum of the refractive indices weighted by the weight content in the particle.
- composite particles mention may, for example, be made of platelets of mica (60%) covered with TiO 2 (40%) , with an average refractive index of 1.9 (0.6x1.5+0.4x2.5) ; inclusions of titanium oxide (40%) in a matrix of alumina (60%) , with an average refractive index of 1.96 (0.6x1.6+0.4x2.5) .
- boron nitride particles such as PUHP1030L from Saint Gobain Ceramics and UHP-1010 from Carborundum.
- boron nitride particles having a volume average size D50 of less than 6 ⁇ m such as the boron nitride particles sold under the name PUHP1030L by Saint Gobain Ceramics, having a volume average size of 3 ⁇ m.
- the white particle is present in an amount ranging from 0.1 wt. %to 1 wt. %, preferably from 0.15 wt. %to 0.8 wt. %, more preferably from 0.2 wt. %to 0.7 wt. %, relative to the total weight of the composition.
- composition of the present invention comprises at least one acrylic acid polymer.
- the acrylic acid polymer is selected from acrylic acid homopolymers and copolymers containing one or more monomers selected from acrylic acid, substituted acrylic acids, and salts and esters of these acrylic acids and the substituted acrylic acids.
- copolymers is understood to mean both copolymers obtained from two types of monomers and those obtained from more than two types of monomers, such as terpolymers obtained from three types of monomers.
- hydrophobic group or “hydrophobic unit” is intended to mean a radical possessing a saturated or unsaturated and linear or branched hydrocarbon chain comprising at least 8 carbon atoms, preferably from 10 to 30 carbon atoms.
- the acrylic acid polymer is selected from copolymers of:
- R 1 denotes H or CH 3 or C 2 H 5 , that is to say acrylic acid, methacrylic acid or ethacrylic acid monomers
- R 2 denotes H or CH 3 or C 2 H 5 (that is to say, acrylate, methacrylate or ethacrylate units) and preferably H (acrylate units) or CH 3 (methacrylate units) and R 3 denotes a C 10 -C 30 alkyl radical.
- the C 10 -C 30 alkyl esters of unsaturated carboxylic acids are preferably selected from lauryl acrylate, stearyl acrylate, decyl acrylate, isodecyl acrylate, dodecyl acrylate and the corresponding methacrylates, such as lauryl methacrylate, stearyl methacrylate, decyl methacrylate, isodecyl methacrylate and dodecyl methacrylate, and their mixtures.
- the acrylic acid polymer is crosslinked.
- crosslinking agent which is a well-known copolymerizable polyethylenic unsaturated monomer, such as diallyl phthalate, allyl (meth) acrylate, divinylbenzene, (poly) ethylene glycol dimethacrylate and methylenebisacrylamide.
- Use will more particularly be made of those composed of 95wt%to 60wt%of acrylic acid (hydrophilic unit) , 4wt %to 40wt%of C 10 -C 30 alkyl acrylate (hydrophobic unit) and 0 wt%to 6wt%of crosslinking polymerizable monomer or else of those composed of 98wt%to 96wt%of acrylic acid (hydrophilic unit) , 1wt%to 4wt%of C 10 -C 30 alkyl acrylate (hydrophobic unit) and 0.1 wt%to 0.6wt%of crosslinking polymerizable monomer, such as those described above.
- These copolymers are commercially available as 1342, 1382, Pemulen TR-1, and Pemulen TR-2, from B.F. Goodrich.
- the acrylic acid polymer is present in amount ranging from 0.1 wt. %to 3 wt. %, preferably from 0.2 wt. %to 2 wt. %, more preferably from 0.3 wt. %to 1 wt. %, relative to the total weight of the composition.
- composition of the present invention comprises at least one 2-acrylamido-2-methylpropanesulfonic acid (AMPS) polymer.
- AMPS 2-acrylamido-2-methylpropanesulfonic acid
- the AMPS polymers can be crosslinked or non-crosslinked homopolymers or copolymers comprising at least acrylamido-2-methylpropanesulfonic acid monomer, optionally in a form partially or totally neutralized with ammonia, sodium hydroxide or potassium hydroxide.
- Representative AMPS polymers are those commercially available from THE LUBRIZOL CORPORATION under the name
- AMPS polymers are preferably totally neutralized or virtually totally neutralized, i.e. at least 90%neutralized.
- the crosslinking agents may be chosen from the polyolefinically unsaturated compounds commonly used for the crosslinking of polymers obtained by free-radical polymerization.
- crosslinking agents examples include divinylbenzene, diallyl ether, dipropylene glycol diallyl ether, polyglycol diallyl ethers, triethylene glycol divinyl ether, hydroquinone diallyl ether, ethylene glycol or tetraethylene glycol di (meth) acrylate, trimethylolpropane triacrylate, methylenebisacrylamide, methylenebismethacrylamide, triallylamine, triallyl cyanurate, diallyl maleate, tetraallylethylenediamine, tetraallyloxyethane, trimethylolpropane diallyl ether, allyl (meth) acrylate, allylic ethers of alcohols of the sugar series, or other allylic or vinyl ethers of polyfunctional alcohols, and also allylic esters of phosphoric and/or vinylphosphonic acid derivatives, or mixtures of these compounds.
- the crosslinking agent is chosen from methylenebis-acrylamide, allyl methacrylate and trimethylolpropane triacrylate (TMPTA) .
- TMPTA trimethylolpropane triacrylate
- the degree of crosslinking generally ranges from 0.01 mol%to 10 mol%and more particularly from 0.2 mol%to 2 mol%relative to the polymer.
- the AMPS polymer in accordance with the invention is water-soluble or water-dispersible. In this case they are:
- copolymers obtained from AMPS and from one or more hydrophilic or hydrophobic ethylenically unsaturated monomers and, if they are crosslinked, one or more crosslinking agents such as those defined above.
- these copolymers may not comprise a fatty chain and are preferably present in small amounts.
- fatty chain means any hydrocarbon-based chain containing at least 7 carbon atoms.
- water-soluble or water-dispersible means polymers which, when introduced into an aqueous phase at 25°C, to a mass concentration equal to 1%, make it possible to obtain a macroscopically homogeneous and transparent solution, i.e. a solution that has a maximum light transmittance value, at a wavelength equal to 500 nm, through a sample 1 cm thick, of at least 60%and preferably of at least 70%.
- the "homopolymers" according to the invention are preferably crosslinked and neutralized.
- the AMPS homopolymers according to the invention are preferably optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid homopolymers, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) sold by the company Clariant under the name Hostacerin (CTFA name: ammonium polyacryldimethyltauramide) .
- CTFA name ammonium polyacryldimethyltauramide
- the water-soluble or water-dispersible AMPS copolymers according to the invention contain water-soluble ethylenically unsaturated monomers, hydrophobic monomers or mixtures thereof.
- the water-soluble comonomers may be ionic or nonionic.
- ionic water-soluble comonomers examples that may be mentioned include the following compounds and the salts thereof:
- - R 1 is chosen from H, -CH 3 , -C 2 H 5 and-C 3 H 7
- - X 1 is chosen from alkyl ethers of-OR 2 type in which R 2 is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbon atoms, substituted with at least one sulfonic (-SO 3 -) and/or sulfate (-SO 4 -) and/or phosphate (-PO 4 H 2 -) group.
- R 2 is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbon atoms, substituted with at least one sulfonic (-SO 3 -) and/or sulfate (-SO 4 -) and/or phosphate (-PO 4 H 2 -) group.
- nonionic water-soluble comonomers examples that may be mentioned include:
- N-vinyllactams comprising a cyclic alkyl group containing 4 to 9 carbon atoms, such as n-vinylpyrrolidone, N-butyrolactam and N-vinylcaprolactam,
- - R 15 is chosen from H, -CH 3 , -C 2 H 5 and-C 3 H 7
- - X 2 is chosen from alkyl ethers of-OR 16 type in which R 16 is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbons, optionally substituted with a halogen atom (iodine, bromine, chlorine or fluorine) ; ahydroxyl group (-OH) ; ether.
- R 16 is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbons, optionally substituted with a halogen atom (iodine, bromine, chlorine or fluorine) ; ahydroxyl group (-OH) ; ether.
- fatty-chain-free hydrophobic comonomers examples that may be mentioned include:
- silicone derivatives which lead to silicone polymers after polymerization, such as methacryloxypropyltris (trimethylsiloxy) silane and silicone methacrylamides,
- - R 23 is chosen from H, -CH 3 , -C 2 H 5 and-C 3 H 7
- R 24 is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbon atoms.
- the AMPS polymer of the invention preferably have a molar mass ranging from 50 000 g/mol to 10 000 000 g/mol, preferably from 80 000 g/mol to 8 000 000 g/mol and even more preferably from 100 000 g/mol to 7 000 000 g/mol.
- water-soluble or water-dispersible AMPS homopolymers in accordance with the invention include crosslinked or non-crosslinked polymers of sodium acrylamido-2-methylpropanesulfonate, such as the polymer used in the commercial product 800 (CTFA name: Sodium Polyacryloyldimethyltaurate) ; or ammonium polyacryloyldimethyl taurate.
- CTFA name Sodium Polyacryloyldimethyltaurate
- crosslinked AMPS copolymer is HMS, ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer
- non-crosslinked AMPS copolymer is SNC, ammonium acryloyldimethyltaurate/steareth-8 methacrylate copolymer.
- water-soluble or water-dispersible AMPS copolymers examples include:
- CTFA name Polyacrylamide/C 13 -C 14 Isoparaffin/Laureth-7) or the copolymer used in the commercial product sold under the trade name 600 (CTFA name: Acrylamide/Sodium Acryloyldimethyltaurate/Isohexadecane/Polysorbate-80) by the company SEPPIC;
- AMPS/sodium acrylate copolymer such as the copolymer used in the commercial product sold under the name EG by the company SEPPIC (CTFA name: Acrylamide/Sodium Acryloyldimethyltaurate/Isohexadecane/Polysorbate-80) ;
- AMPS/hydroxyethyl acrylate copolymer such as the copolymer used in the commercial product sold under the name NS by the company SEPPIC (CTFA name: Hydroxyethyl acrylate/Sodium Acryloyldimethyltaurate copolymer (and) Squalane (and) Polysorbate-60) ;
- the preferred polymers are more particularly sodium acrylamido-2-methylpropanesulfonate homopolymer, such as the homopolymer used in the commercial product 800, or ammonium polyacryloyldimethyl taurate; and AMPS/hydroxyethyl acrylate copolymers, such as the copolymer used in the commercial product sold under the name Simulgel NS, or ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer.
- sodium acrylamido-2-methylpropanesulfonate homopolymer such as the homopolymer used in the commercial product 800, or ammonium polyacryloyldimethyl taurate
- AMPS/hydroxyethyl acrylate copolymers such as the copolymer used in the commercial product sold under the name Simulgel NS, or ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer.
- the AMPS polymer is present in an amount ranging from 0.1 wt.%to 1.5 wt. %, preferably from 0.2 wt. %to 1 wt. %, more preferably from 0.3 wt.%to 0.7 wt. %, relative to the total weight of the composition.
- the composition according to the present invention comprises glycerin.
- glycerin is present in an amount ranging from 25 wt. %to 80 wt. %, preferably from 25 wt. %to 60 wt. %, more preferably from 30 wt. %to 50 wt. %, relative to the total weight of the composition.
- the weight ratio of the AMPS polymer to glycerin is between 1: 200 and 1: 20, preferably between 1: 150 and 1: 40.
- composition according to the present invention comprises further comprises at least one additional polyol other than glycerin.
- the composition according to the present invention comprises an additional polyol other than glycerin comprising 2-10 carbon atoms, for example at least one glycol, such as propylene glycol, dipropylene glycol, ethylene glycol, butylene glycol, and pentylene glycol.
- an additional polyol other than glycerin comprising 2-10 carbon atoms, for example at least one glycol, such as propylene glycol, dipropylene glycol, ethylene glycol, butylene glycol, and pentylene glycol.
- the composition according to the present invention comprises at least one additional polyol selected from propylene glycol, dipropylene glycol, ethylene glycol, butylene glycol, pentylene glycol, and a combination thereof.
- the composition according to the present invention comprises propylene glycol and dipropylene glycol.
- the additional polyol other than glycerin is present in an amount ranging from 10 wt. %to 60 wt. %, preferably from 15 wt. %to 45 wt. %, more preferably from 18 wt. %to 35 wt. %, relative to the total weight of the composition.
- the composition according to the present invention can deliver a fresh feeling to the skin.
- the weight ratio of the acrylic acid polymer to the additional polyol other than glycerin is between 1: 200 and 1: 20, preferably between 1: 150 and 1: 30.
- composition according to the present invention may comprise an additional active ingredient commonly used in cosmetic field.
- the composition of the present invention comprises at least one additional active ingredient having an effect on the skin, such antioxidants such as ascorbic acid and polygonum cuspidatum root extract, free-radical scavengers such as ferulic acid, moisturizers, liporegulators, anti-acne agents, antiseborrhoeic agents, anti-ageing agents, softeners, anti-wrinkle agents, anti-inflammatories, refreshing agents, cicatrizing agents, vascular protective agents, antibacterials, antifungals, exfoliating agents, antiperspirants, deodorants, skin conditioners, desensitizing agents, immunomodulators and nourishing agents, moisture absorbers, soothing active ingredients and sebum absorbing ingredients.
- antioxidants such as ascorbic acid and polygonum cuspidatum root extract
- free-radical scavengers such as ferulic acid, moisturizers, liporegulators, anti-acne agents, antiseborrhoeic agents, anti
- the additional active ingredient contained in the composition according to the present invention is water-soluble.
- the additional active ingredients and the concentrations thereof can be adjusted based on the desired properties of the composition of the present invention.
- composition of the present invention may also contain one or more additional adjuvants that are common in cosmetics or dermatology.
- additional adjuvants examples include preservative agents, pH-adjusting agents, fragrances, pigments, and mixtures thereof.
- the present invention provides a composition for brightening or toning the skin in the form of a gel, comprising, in a hydrophilic phase, relative to the total weight of the composition,
- APMS 2-acrylamido-2-methylpropanesulfonic acid
- v) from from 18 wt. %to 35 wt. %of at least one additional polyol selected from propylene glycol, dipropylene glycol, ethylene glycol, butylene glycol, pentylene glycol, and a combination thereof.
- composition according to the present invention may be anhydrous.
- anhydrous it means that no water is added on purpose and the water content of the composition is less than 2 wt. %, preferably less than 0.5 wt. %, particularly less than 0.1 wt. %, relative to the total weight of the composition. In particular, there is no water in the composition.
- composition according to the present invention may not comprise any surfactant.
- composition according to the present invention is intended for topical application and can especially constitute a composition intended for brightening or toning the skin, and especially human skin
- the present invention relates to a cosmetic process for brightening or toning the skin, comprising applying the composition as defined above to the skin.
- the skin is human skin.
- compositions of invention examples (IE. ) 1-5 and comparative examples (CE. ) 1-6 were prepared according to the amounts given in Table 3. The amount of each component is given in%by weight of the total weight of the composition containing it.
- compositions of comparative invention 1-2 comprise silica silylate instead of acrylic acid polymer.
- compositions of comparative invention 3-4 comprise poloxamer 338 instead of acrylic acid polymer.
- Composition of comparative invention 5 comprises xanthan gum instead of acrylic acid polymer.
- Composition of comparative invention 6 comprises Tween 20 instead of acrylic acid polymer.
- compositions above were prepared as follows, taking that of invention example 1 as an example:
- composition of invention examples 1-5 and comparative examples 1-6 was evaluated in terms of viscosity and stability.
- the viscosity was measured at 25°C, using a Rheomat 100 Plus viscometer equipped with a spindle M4, the measurement being performed after 10 minutes of rotation of the spindle in a sample (after which time stabilization of the viscosity and of the spin speed of the spindle are observed) , at a shear rate of 200 rpm.
- the stability will be evaluated as PASS if the composition remains a uniform gel after all of the stability tests at different temperature and that cycle stability test, otherwise, it will be evaluated as FAILED.
- composition according to the present invention has a suitable viscosity for topical application and is stable.
- composition of invention examples 1-5 can deliver a brightening or toning effect to the skin.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
A composition for brightening or toning the skin in the form of a gel comprises, in a hydrophilic phase, i) at least one white particle; ii) at least one acrylic acid polymer; iii) at least one 2-acrylamido-2-methylpropanesulfonic acid (AMPS) polymer; and iv) glycerin. A cosmetic process for brightening or toning the skin comprises applying the composition to the skin.
Description
The present invention relates to a cosmetic composition. In particular, the present invention relates to a composition for brightening or toning the skin, in particular human skin.
BACKGROUND ART
The colour of human skin colour depends on various factors, and in particular on the seasons of the year, on race and on gender; it is mainly determined by the nature and the concentration of melanin produced by melanocytes. Melanocytes are specialized cells which synthesize melanin by means of specific organelles, melanosomes. In addition, at various times in their life, certain individuals experience the appearance of dark and/or coloured spots on the skin and more especially on the hands, which give the skin heterogeneity.
For various reasons associated in particular with greater comfort of use (softness, emollience and the like) , current compositions for caring for and/or making up keratin materials, in particular the skin, are usually in the form of an emulsion of the oil-in-water (O/W) type consisting of an aqueous dispersing continuous phase and an oily dispersed discontinuous phase, or of an emulsion of the water-in-oil (W/O) type consisting of an oily dispersing continuous phase and an aqueous dispersed discontinuous phase.
O/W emulsions are the ones most sought in the cosmetics field, since they comprise an aqueous phase as the external phase, which gives them, when applied to the skin, a fresher, less greasy and lighter feel than W/O emulsions.
However, due to their natural feature, the conventional oil-in-water emulsions are not totally satisfying, in particular in terms of brightening or toning of the skin.
Efforts have been made to introduce toning active agents into the oil-in-water emulsions. However, it is difficult to obtain a stable composition delivering a good brightening or toning on the skin.
Efforts have also been made to introduce toning pigments into the oil-in-water emulsions. Unfortunately, such pigments generally negatively impact the stability of the emulsions, thereby somewhat complicating the manufacture of the emulsion.
It is also desired that the product for brightening or toning the skin has a suitable viscosity so that there are no droplets falling from the consumer’s hand and it is not difficult to apply the product when the product is applied on the skin.
Therefore, there is a need for formulating a composition for brightening or toning the skin, which can provide brightening or toning effect on the skin, and which has suitable viscosity and is stable.
SUMMARY OF THE INVENTION
An object of the present invention is to provide a composition for brightening or toning the skin, which can provide brightening or toning effect on the skin, and which has suitable viscosity and is stable.
Another object of the present invention is to provide a cosmetic process for brightening or toning the skin.
Thus, according to one aspect, the present invention provides a composition for brightening or toning the skin in the form of a gel, comprising, in a hydrophilic phase,
i) at least one white particle;
ii) at least one acrylic acid polymer;
iii) at least one 2-acrylamido-2-methylpropanesulfonic acid (AMPS) polymer;
and
iv) glycerin.
Firstly, the composition according to the present invention has a brightening or toning effect to the skin, in particular human skin.
Secondly, the composition according to the present invention has a viscosity of from 4500 to 16000 mpa.s as determined with a Rheomat 100 Plus viscometer equipped with a spindle M4 at 25℃, so that there are no droplets falling from the consumer’s hand and it is not difficult to apply the composition when the composition is applied on the skin.
In addition, the composition according to the present invention is stable over time.
According to another aspect, the present invention provides a cosmetic process for brightening or toning the skin, comprising applying the composition as defined above to the skin.
Other subjects and characteristics, aspects and advantages of the present invention will emerge even more clearly on reading the detailed description and the examples that follow.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art the present invention belongs to. When the definition of a term in the present description conflicts with the meaning as commonly understood by those skilled in the art the present invention belongs to, the definition described herein shall apply.
In that which follows and unless otherwise indicated, the limits of a range of values are included within this range, in particular in the expressions "between... and…" and "ranging from... to..." .
Moreover, the expression "at least one" used in the present description is equivalent to the expression "one or more" .
Throughout the instant application, the term “comprising” is to be interpreted as encompassing all specifically mentioned features as well as optional, additional, unspecified ones. As used herein, the use of the term “comprising” also discloses the embodiment wherein no features other than the specifically mentioned features are present (i.e. “consisting of” ) .
Unless otherwise specified, all numerical values expressing amount of ingredients and the like which are used in the description and claims are to be understood as being modified by the term “about” . Accordingly, unless indicated to the contrary, the numerical values and parameters described herein are approximate values which are capable of being changed according to the desired purpose as required.
For the purposes of the present invention, the term “keratin material” is intended to cover human skin. Human skin, in particular skin of face, neck, back and hand is most particularly considered according to the present invention.
All percentages in the present invention refer to weight percentage, unless otherwise specified.
According to the first aspect, the composition in the form of a gel according to the present invention comprising, in a hydrophilic phase,
i) at least one white particle;
ii) at least one at least one acrylic acid polymer;
iii) at least one 2-acrylamido-2-methylpropanesulfonic acid (AMPS) polymer;
and
iv) glycerin.
White particles
The cosmetic composition according to the present invention comprises at least one white particles.
The term "white" is intended to mean particles having the colour white and its derivatives (off-white, alabaster white, etc. ) , as opposed to primary colours and derivatives.
In some embodiment, the white particles used are inorganic particles.
In particular, the white particles have a lightness value L*close to 100 in the CIELab76 system.
Preferably, the white particles is characterized by 0.3 μm<D50<40 μm.
The volume average size (D50) is a parameter for particle size distribution, referring to the maximum particle diameter below which 50%of the sample volume exists (see in “A Basic Guide To Particle Characterization” , page 10, published by Malvern Instruments Limited in 2012) .
The volume average size (D50) of the particles may be measured by static light scattering using a commercial granulometer such as the MasterSizer 3000 machine from Malvern. The data are processed on the basis of the Mie scattering theory. This theory, which is exact for isotropic particles, makes it possible to determine, in the case of non-spherical particles, an "effective" particle diameter. This theory is especially described in the publication by Van de Hulst, H.C., "Light Scattering by Small Particles, " Chapters 9 and 10, Wiley, New York, 1957.
The white particles according to the present invention have a continuous effect, which is controlled by the resolution capacity of the eye. Since said capacity is around 40 μm, particles having a volume average size (D50) of less than 40 μm, preferably less than 25 μm and even better still less than or equal to 6 μm are therefore considered. However, it is ensured that particles of which the D50 is greater than 0.3 μm and preferentially 0.5 μm are taken, so as not to have too great a loss of opacity, which would be extremely detrimental to the desired effect.
Thus, the composition of the present invention preferably comprises at least white particles having a volume size (D50) of less than 40 μm, preferably between 0.3 and 25 μm and better still between 0.3 and 6 μm, or even between 0.5 and 3 μm.
These particles may be made of one material or else be composites. For example, these particles may be selected from boron nitride, silica, pearl, mica, synthetic mica, mica based pearl pigment particles, composite particles comprising titanium dioxide and a substrate selected from alumina, silica, barium sulfate, glass, mica and synthetic mica, or mixtures thereof.
According to a preferred embodiment, the particles are boron nitride particles.
According to another embodiment, the particles are composite particles comprising titanium dioxide and an alumina substrate.
According to another embodiment, the particles are composite particles comprising titanium dioxide and a mica substrate.
The white particles are advantageously boron nitride particles, preferentially having a volume average size of from 0.3 to 6μm.
Preferably, the white particles according to the present invention have an average refractive index of between 1.4 and 2.2. This is because, if the particle has a refractive index above 2.2, the opacity of the composition is too high, and if this index is below 1.4, the lightening effect is not sufficient. The average refractive index is defined as being the sum of the refractive indices weighted by the weight content in the particle.
As examples of composite particles, mention may, for example, be made of platelets of mica (60%) covered with TiO
2 (40%) , with an average refractive index of 1.9 (0.6x1.5+0.4x2.5) ; inclusions of titanium oxide (40%) in a matrix of alumina (60%) , with an average refractive index of 1.96 (0.6x1.6+0.4x2.5) .
The refractive indices of some materials are listed in Table 1:
Table 1
| Material | Refractive index |
| Mica | 1.4-1.7 |
| Bismuth oxychloride | 2.15 |
| Fe 3O 4 | 2.4 |
| TiO 2 (anatase) | 2.5 |
| TiO 2 (rutile) | 2.7 |
| Boron nitride | 1.74 |
| Alumina (amorphous) | 1.6 |
By way of example of particles, mention may be made of boron nitride particles, such as PUHP1030L from Saint Gobain Ceramics and UHP-1010 from Carborundum.
According to one particularly preferred embodiment, use will be made of boron nitride particles having a volume average size D50 of less than 6 μm, such as the boron nitride particles sold under the name PUHP1030L by Saint Gobain Ceramics, having a volume average size of 3 μm.
Advantageously, the white particle is present in an amount ranging from 0.1 wt. %to 1 wt. %, preferably from 0.15 wt. %to 0.8 wt. %, more preferably from 0.2 wt. %to 0.7 wt. %, relative to the total weight of the composition.
Acrylic acid polymers
The composition of the present invention comprises at least one acrylic acid polymer.
The acrylic acid polymer is selected from acrylic acid homopolymers and copolymers containing one or more monomers selected from acrylic acid, substituted acrylic acids, and salts and esters of these acrylic acids and the substituted acrylic acids.
The term "copolymers" is understood to mean both copolymers obtained from two types of monomers and those obtained from more than two types of monomers, such as terpolymers obtained from three types of monomers.
Their chemical structure more particularly comprises at least one hydrophilic unit and at least one hydrophobic unit. The term "hydrophobic group" or "hydrophobic unit" is intended to mean a radical possessing a saturated or unsaturated and linear or branched hydrocarbon chain comprising at least 8 carbon atoms, preferably from 10 to 30 carbon atoms.
Preferably, the acrylic acid polymer is selected from copolymers of:
at least one monomer of following formula (1) :
in which R
1 denotes H or CH
3 or C
2H
5, that is to say acrylic acid, methacrylic acid or ethacrylic acid monomers, and
at least one monomer of unsaturated carboxylic acid (C
10-C
30) alkyl ester type which corresponds to the monomer of following formula (2) :
in which R
2 denotes H or CH
3 or C
2H
5 (that is to say, acrylate, methacrylate or ethacrylate units) and preferably H (acrylate units) or CH
3 (methacrylate units) and R
3 denotes a C
10-C
30 alkyl radical.
The C
10-C
30 alkyl esters of unsaturated carboxylic acids are preferably selected from lauryl acrylate, stearyl acrylate, decyl acrylate, isodecyl acrylate, dodecyl acrylate and the corresponding methacrylates, such as lauryl methacrylate, stearyl methacrylate, decyl methacrylate, isodecyl methacrylate and dodecyl methacrylate, and their mixtures.
Preferably, the acrylic acid polymer is crosslinked.
Use will more particularly be made, among the acrylic polymers of this type, of copolymers obtained from the polymerization of:
(i) acrylic acid,
(ii) an ester of formula (2) described above in which R
2 denotes H or CH
3 and R
3 denotes an alkyl radical having from 10 to 30 carbon atoms, and
(iii) a crosslinking agent which is a well-known copolymerizable polyethylenic unsaturated monomer, such as diallyl phthalate, allyl (meth) acrylate, divinylbenzene, (poly) ethylene glycol dimethacrylate and methylenebisacrylamide.
Use will more particularly be made of those composed of 95wt%to 60wt%of acrylic acid (hydrophilic unit) , 4wt %to 40wt%of C
10-C
30 alkyl acrylate (hydrophobic unit) and 0 wt%to 6wt%of crosslinking polymerizable monomer or else of those composed of 98wt%to 96wt%of acrylic acid (hydrophilic unit) , 1wt%to 4wt%of C
10-C
30 alkyl acrylate (hydrophobic unit) and 0.1 wt%to 0.6wt%of crosslinking polymerizable monomer, such as those described above.
Preference is very particularly given according to the present invention, among the polymers above, to acrylate/C
10-C
30 alkyl acrylate copolymers (INCI name: Acrylates/C10-30 Alkyl Acrylate Crosspolymer) . These copolymers are commercially available as
1342,
1382, Pemulen TR-1, and Pemulen TR-2, from B.F. Goodrich.
Advantageously, the acrylic acid polymer is present in amount ranging from 0.1 wt. %to 3 wt. %, preferably from 0.2 wt. %to 2 wt. %, more preferably from 0.3 wt. %to 1 wt. %, relative to the total weight of the composition.
AMPS polymers
The composition of the present invention comprises at least one 2-acrylamido-2-methylpropanesulfonic acid (AMPS) polymer.
The AMPS polymers can be crosslinked or non-crosslinked homopolymers or copolymers comprising at least acrylamido-2-methylpropanesulfonic acid monomer, optionally in a form partially or totally neutralized with ammonia, sodium hydroxide or potassium hydroxide. Representative AMPS polymers are those commercially available from THE LUBRIZOL CORPORATION under the name
AMPS polymers are preferably totally neutralized or virtually totally neutralized, i.e. at least 90%neutralized.
When the polymers are crosslinked, the crosslinking agents may be chosen from the polyolefinically unsaturated compounds commonly used for the crosslinking of polymers obtained by free-radical polymerization.
Examples of crosslinking agents that may be mentioned include divinylbenzene, diallyl ether, dipropylene glycol diallyl ether, polyglycol diallyl ethers, triethylene glycol divinyl ether, hydroquinone diallyl ether, ethylene glycol or tetraethylene glycol di (meth) acrylate, trimethylolpropane triacrylate, methylenebisacrylamide, methylenebismethacrylamide, triallylamine, triallyl cyanurate, diallyl maleate, tetraallylethylenediamine, tetraallyloxyethane, trimethylolpropane diallyl ether, allyl (meth) acrylate, allylic ethers of alcohols of the sugar series, or other allylic or vinyl ethers of polyfunctional alcohols, and also allylic esters of phosphoric and/or vinylphosphonic acid derivatives, or mixtures of these compounds.
Preferably, the crosslinking agent is chosen from methylenebis-acrylamide, allyl methacrylate and trimethylolpropane triacrylate (TMPTA) . The degree of crosslinking generally ranges from 0.01 mol%to 10 mol%and more particularly from 0.2 mol%to 2 mol%relative to the polymer.
The AMPS polymer in accordance with the invention is water-soluble or water-dispersible. In this case they are:
- either "homopolymers" comprising only AMPS monomers and, if they are crosslinked, one or more crosslinking agents such as those defined above;
- or copolymers obtained from AMPS and from one or more hydrophilic or hydrophobic ethylenically unsaturated monomers and, if they are crosslinked, one or more crosslinking agents such as those defined above. When the said copolymers comprise hydrophobic ethylenically unsaturated monomers, these monomers may not comprise a fatty chain and are preferably present in small amounts.
For the purposes of the AMPS polymer according to the present invention, the term "fatty chain" means any hydrocarbon-based chain containing at least 7 carbon atoms.
The term "water-soluble or water-dispersible" means polymers which, when introduced into an aqueous phase at 25℃, to a mass concentration equal to 1%, make it possible to obtain a macroscopically homogeneous and transparent solution, i.e. a solution that has a maximum light transmittance value, at a wavelength equal to 500 nm, through a sample 1 cm thick, of at least 60%and preferably of at least 70%.
The "homopolymers" according to the invention are preferably crosslinked and neutralized.
The AMPS homopolymers according to the invention are preferably optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid homopolymers, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) sold by the company Clariant under the name Hostacerin
(CTFA name: ammonium polyacryldimethyltauramide) .
The water-soluble or water-dispersible AMPS copolymers according to the invention contain water-soluble ethylenically unsaturated monomers, hydrophobic monomers or mixtures thereof.
The water-soluble comonomers may be ionic or nonionic.
Among the ionic water-soluble comonomers, examples that may be mentioned include the following compounds and the salts thereof:
- (meth) acrylic acid,
- styrenesulfonic acid,
- vinylsulfonic acid and (meth) allylsulfonic acid,
- vinylphosphonic acid,
- maleic acid,
- itaconic acid,
- crotonic acid,
- the water-soluble vinyl monomers of formula (A) below:
in which:
- R
1 is chosen from H, -CH
3, -C
2H
5 and-C
3H
7
- X
1 is chosen from alkyl ethers of-OR
2 type in which R
2 is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbon atoms, substituted with at least one sulfonic (-SO
3-) and/or sulfate (-SO
4-) and/or phosphate (-PO
4H
2-) group.
Among the nonionic water-soluble comonomers, examples that may be mentioned include:
- (meth) acrylamide,
- N-vinylacetamide and N-methyl-N-vinylacetamide,
- N-vinylformamide and N-methyl-N-vinylformamide,
- maleic anhydride,
- vinylamine,
- N-vinyllactams comprising a cyclic alkyl group containing 4 to 9 carbon atoms, such as n-vinylpyrrolidone, N-butyrolactam and N-vinylcaprolactam,
- vinyl alcohol of formula CH
2=CHOH,
- the water-soluble vinyl monomers of formula (B) below:
in which:
- R
15 is chosen from H, -CH
3, -C
2H
5 and-C
3H
7
- X
2 is chosen from alkyl ethers of-OR
16 type in which R
16 is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbons, optionally substituted with a halogen atom (iodine, bromine, chlorine or fluorine) ; ahydroxyl group (-OH) ; ether.
Mention is made, for example, of glycidyl (meth) acrylate, hydroxyethyl methacrylate and (meth) acrylates of ethylene glycol, of diethylene glycol or of polyalkylene glycol.
Among the fatty-chain-free hydrophobic comonomers, examples that may be mentioned include:
- styrene and its derivatives, such as 4-butylstyrene, a-methylstyrene and vinyltoluene,
- vinyl acetate of formula CH
2=CH-OCOCH
3;
- vinyl ethers of formula CH
2=CHOR in which R is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbons;
- acrylonitrile,
- caprolactone,
- vinyl chloride and vinylidene chloride,
- silicone derivatives, which lead to silicone polymers after polymerization, such as methacryloxypropyltris (trimethylsiloxy) silane and silicone methacrylamides,
- the hydrophobic vinyl monomers of formula (C) below:
in which:
- R
23 is chosen from H, -CH
3, -C
2H
5 and-C
3H
7
- X
3 is chosen from:
- alkyl ethers of-OR
24 type in which R
24 is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbon atoms.
Mention is made, for example, of methyl methacrylate, ethyl methacrylate, n-butyl (meth) acrylate, tert-butyl (meth) acrylate, cyclohexyl acrylate and isobornyl acrylate and 2-ethylhexyl acrylate.
The AMPS polymer of the invention preferably have a molar mass ranging from 50 000 g/mol to 10 000 000 g/mol, preferably from 80 000 g/mol to 8 000 000 g/mol and even more preferably from 100 000 g/mol to 7 000 000 g/mol.
Examples of water-soluble or water-dispersible AMPS homopolymers in accordance with the invention that may be mentioned include crosslinked or non-crosslinked polymers of sodium acrylamido-2-methylpropanesulfonate, such as the polymer used in the commercial product
800 (CTFA name: Sodium Polyacryloyldimethyltaurate) ; or ammonium polyacryloyldimethyl taurate. For example, crosslinked AMPS copolymer is
HMS, ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer; non-crosslinked AMPS copolymer is
SNC, ammonium acryloyldimethyltaurate/steareth-8 methacrylate copolymer.
Examples of water-soluble or water-dispersible AMPS copolymers in accordance with the invention that may be mentioned include:
- acrylamide/sodium acrylamido-2-methylpropanesulfonate crosslinked copolymers, such as the copolymer used in the commercial product
305 (CTFA name: Polyacrylamide/C
13-C
14 Isoparaffin/Laureth-7) or the copolymer used in the commercial product sold under the trade name
600 (CTFA name: Acrylamide/Sodium Acryloyldimethyltaurate/Isohexadecane/Polysorbate-80) by the company SEPPIC;
- copolymers of AMPS and of vinylpyrrolidone or of vinylformamide, such as the copolymer used in the commercial product sold under the name
AVC by the company Clariant (CTFA name: Ammonium Acryloyldimethyltaurate/VP Copolymer) but neutralized with sodium hydroxide or potassium hydroxide;
- copolymers of AMPS and of sodium acrylate, for instance AMPS/sodium acrylate copolymer such as the copolymer used in the commercial product sold under the name
EG by the company SEPPIC (CTFA name: Acrylamide/Sodium Acryloyldimethyltaurate/Isohexadecane/Polysorbate-80) ;
- copolymers of AMPS and of hydroxyethyl acrylate, for instance AMPS/hydroxyethyl acrylate copolymer, such as the copolymer used in the commercial product sold under the name
NS by the company SEPPIC (CTFA name: Hydroxyethyl acrylate/Sodium Acryloyldimethyltaurate copolymer (and) Squalane (and) Polysorbate-60) ;
- ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer.
The preferred polymers are more particularly sodium acrylamido-2-methylpropanesulfonate homopolymer, such as the homopolymer used in the commercial product
800, or ammonium polyacryloyldimethyl taurate; and AMPS/hydroxyethyl acrylate copolymers, such as the copolymer used in the commercial product sold under the name Simulgel NS, or ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer.
Advantageously, the AMPS polymer is present in an amount ranging from 0.1 wt.%to 1.5 wt. %, preferably from 0.2 wt. %to 1 wt. %, more preferably from 0.3 wt.%to 0.7 wt. %, relative to the total weight of the composition.
Glycerin
According to the first aspect, the composition according to the present invention comprises glycerin.
Advantageously, glycerin is present in an amount ranging from 25 wt. %to 80 wt. %, preferably from 25 wt. %to 60 wt. %, more preferably from 30 wt. %to 50 wt. %, relative to the total weight of the composition.
For the purpose of the present invention, preferably, the weight ratio of the AMPS polymer to glycerin is between 1: 200 and 1: 20, preferably between 1: 150 and 1: 40.
Additional polyols
Preferably, the composition according to the present invention comprises further comprises at least one additional polyol other than glycerin.
Preferably, the composition according to the present invention comprises an additional polyol other than glycerin comprising 2-10 carbon atoms, for example at least one glycol, such as propylene glycol, dipropylene glycol, ethylene glycol, butylene glycol, and pentylene glycol.
In some embodiments, the composition according to the present invention comprises at least one additional polyol selected from propylene glycol, dipropylene glycol, ethylene glycol, butylene glycol, pentylene glycol, and a combination thereof.
In a very prefferred embodiment, the composition according to the present invention comprises propylene glycol and dipropylene glycol.
Advantageously, if presents, the additional polyol other than glycerin is present in an amount ranging from 10 wt. %to 60 wt. %, preferably from 15 wt. %to 45 wt. %, more preferably from 18 wt. %to 35 wt. %, relative to the total weight of the composition.
With the presence of the additional polyol other than glycerin, the composition according to the present invention can deliver a fresh feeling to the skin.
For the purpose of the present invention, preferably, the weight ratio of the acrylic acid polymer to the additional polyol other than glycerin is between 1: 200 and 1: 20, preferably between 1: 150 and 1: 30.
Additional active ingredients
In addition to the white particle, the composition according to the present invention may comprise an additional active ingredient commonly used in cosmetic field.
According to some embodiments, the composition of the present invention comprises at least one additional active ingredient having an effect on the skin, such antioxidants such as ascorbic acid and polygonum cuspidatum root extract, free-radical scavengers such as ferulic acid, moisturizers, liporegulators, anti-acne agents, antiseborrhoeic agents, anti-ageing agents, softeners, anti-wrinkle agents, anti-inflammatories, refreshing agents, cicatrizing agents, vascular protective agents, antibacterials, antifungals, exfoliating agents, antiperspirants, deodorants, skin conditioners, desensitizing agents, immunomodulators and nourishing agents, moisture absorbers, soothing active ingredients and sebum absorbing ingredients.
Preferably, the additional active ingredient contained in the composition according to the present invention is water-soluble.
The additional active ingredients and the concentrations thereof can be adjusted based on the desired properties of the composition of the present invention.
Adjuvants
In a known manner, the composition of the present invention may also contain one or more additional adjuvants that are common in cosmetics or dermatology.
Examples of additional adjuvants that may be mentioned include preservative agents, pH-adjusting agents, fragrances, pigments, and mixtures thereof.
The skilled in the art can select the amount of the additional adjuvants so as not to adversely impact the final use of the composition according to the present invention.
According to a preferred embodiment, the present invention provides a composition for brightening or toning the skin in the form of a gel, comprising, in a hydrophilic phase, relative to the total weight of the composition,
i) from 0.1 wt. %to 1 wt. %of boron nitride;
ii) from 0.3 wt. %to 1 wt. %of acrylate/C
10-C
30 alkyl acrylate copolymer;
iii) from 0.3 wt. %to 0.7 wt. %of at least one 2-acrylamido-2-methylpropanesulfonic acid (AMPS) polymer selected from acrylamido-2-methylpropanesulfonate homopolymer, ammonium polyacryloyldimethyl taurate, AMPS/hydroxyethyl acrylate copolymer, ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer, and a combination thereof;
iv) from 30 wt. %to 50 wt. %of glycerin; and
v) from from 18 wt. %to 35 wt. %of at least one additional polyol selected from propylene glycol, dipropylene glycol, ethylene glycol, butylene glycol, pentylene glycol, and a combination thereof.
The composition according to the present invention may be anhydrous.
By "anhydrous" , it means that no water is added on purpose and the water content of the composition is less than 2 wt. %, preferably less than 0.5 wt. %, particularly less than 0.1 wt. %, relative to the total weight of the composition. In particular, there is no water in the composition.
The composition according to the present invention may not comprise any surfactant.
Method and use
The composition according to the present invention is intended for topical application and can especially constitute a composition intended for brightening or toning the skin, and especially human skin
According to another aspect, the present invention relates to a cosmetic process for brightening or toning the skin, comprising applying the composition as defined above to the skin.
In particular, the skin is human skin.
The present invention is illustrated in greater detail by the examples described below, which are given as non-limiting illustrations.
In the examples that follow, the weight percentages are indicated relative to the total weight of the cosmetic composition.
Examples
Main raw materials used, trade names and supplier thereof are listed in Table 2.
Table 2
Invention examples 1-5 and comparative examples 1-6
Compositions of invention examples (IE. ) 1-5 and comparative examples (CE. ) 1-6 were prepared according to the amounts given in Table 3. The amount of each component is given in%by weight of the total weight of the composition containing it.
Table 3
Compositions of comparative invention 1-2 comprise silica silylate instead of acrylic acid polymer.
Compositions of comparative invention 3-4 comprise poloxamer 338 instead of acrylic acid polymer.
Composition of comparative invention 5 comprises xanthan gum instead of acrylic acid polymer.
Composition of comparative invention 6 comprises Tween 20 instead of acrylic acid polymer.
Preparation process:
The compositions above were prepared as follows, taking that of invention example 1 as an example:
1) . mixing glycerin, dipropylene glycol, and propylene glycol and heating the mixture to 80℃;
2) . adding ammonium polyacryloyldimethyl taurate and acrylates/C10-30 alkyl acrylate crosspolymer into the mixture with stirring;
3) . add the remaining ingredients to obtain the composition.
Evaluation
Each composition of invention examples 1-5 and comparative examples 1-6 was evaluated in terms of viscosity and stability.
Viscosity
The viscosity was measured at 25℃, using a Rheomat 100 Plus viscometer equipped with a spindle M4, the measurement being performed after 10 minutes of rotation of the spindle in a sample (after which time stabilization of the viscosity and of the spin speed of the spindle are observed) , at a shear rate of 200 rpm.
Stability
The stability was evaluated as follows:
1) filling 40 mL of a sample into a 60 mL glass bottle and preparing six bottles for each composition to be tested;
2) putting one bottle under the sun (for sun-test) , one bottle at room temperature (RM, 20℃) , one bottle into a refrigerator at 4℃, one bottle into an oven at 37℃, and one bottle into an oven at 45℃ (for stability tests at different temperatures) , and one bottle into an oven with the temperature cycling from-20℃to 20℃ for every 24 hours (for cycle stability) ; and
3) observing the samples’ appearance after 24 hours for the sun-test, 2 months for stability tests at different temperatures or 10 days for cycle stability.
The stability will be evaluated as PASS if the composition remains a uniform gel after all of the stability tests at different temperature and that cycle stability test, otherwise, it will be evaluated as FAILED.
The viscosity and stability of the compositions according to comparative examples and inventive examples were listed in Table 4.
Table 4
It can be also seen that the composition according to the present invention has a suitable viscosity for topical application and is stable.
In addition, the composition of invention examples 1-5 can deliver a brightening or toning effect to the skin.
Claims (15)
- A composition for brightening or toning the skin in the form of a gel, comprising, in a hydrophilic phase,i) at least one white particle;ii) at least one acrylic acid polymer;iii) at least one 2-acrylamido-2-methylpropanesulfonic acid (AMPS) polymer; andiv) glycerin.
- Composition of claim 1, wherein the white particles are selected from boron nitride, silica, pearl, mica, synthetic mica, mica based pearl pigment particles, composite particles comprising titanium dioxide and a substrate selected from alumina, silica, barium sulfate, glass, mica and synthetic mica, or mixtures thereof.
- Composition of claim 1 or 2, wherein the white particles are present in the composition in an amount ranging from 0.1 wt. %to 1 wt. %, preferably from 0.15 wt. %to 0.8 wt. %, more preferably from 0.2 wt. %to 0.7 wt. %, relative to the total weight of the composition.
- Composition of any one of claims 1 to 3, wherein the acrylic acid polymer is selected from acrylic acid homopolymers and copolymers containing one or more monomers selected from acrylic acid, substituted acrylic acids, and salts and esters of these acrylic acids and the substituted acrylic acids.
- Composition of any one of claims 1 to 4, wherein the acrylic acid polymer is selected from copolymers of:at least one monomer of following formula (1) :in which R 1 denotes H or CH 3 or C 2H 5, andat least one monomer of unsaturated carboxylic acid (C 10-C 30) alkyl ester type which corresponds to the monomer of following formula (2) :in which R 2 denotes H or CH 3 or C 2H 5 and R 3 denotes a C 10-C 30 alkyl radical,preferably, the acrylic acid polymer is selected from copolymers obtained from the polymerization of:(i) acrylic acid,(ii) an ester of formula (2) described above in which R 2 denotes H or CH 3 and R 3 denotes an alkyl radical having from 10 to 30 carbon atoms, and(iii) a crosslinking agent selected from diallyl phthalate, allyl (meth) acrylate, divinylbenzene, (poly) ethylene glycol dimethacrylate and methylenebisacrylamide,more preferably, the acrylic acid polymer is acrylate/C 10-C 30 alkyl acrylate copolymers.
- Composition according to any one of claims 1 to 5, wherein the acrylic acid polymer is present in amount ranging from 0.1 wt. %to 3 wt. %, preferably from 0.2 wt. %to 2 wt. %, more preferably from 0.3 wt. %to 1 wt. %, relative to the total weight of the composition.
- Composition according to any of claims 1 to 6, wherein the AMPS polymer is selected from crosslinked or non-crosslinked homopolymers or copolymers comprising at least acrylamido-2-methylpropanesulfonic acid monomer, optionally in a form partially or totally neutralized with ammonia, sodium hydroxide or potassium hydroxide.
- Composition according to any of claims 1 to 7, wherein the AMPS polymer is selected from sodium acrylamido-2-methylpropanesulfonate homopolymer, or ammonium polyacryloyldimethyl taurate homopolymer, AMPS/hydroxyethyl acrylate copolymer, or ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer.
- Composition according to any of claims 1 to 8, wherein the AMPS polymer is present in an amount ranging from 0.1 wt. %to 1.5 wt. %, preferably from 0.2 wt. %to 1 wt. %, more preferably from 0.3 wt. %to 0.7 wt. %, relative to the total weight of the composition.
- Composition according to any of claims 1 to 9, wherein glycerin is present in an amount ranging from 25 wt. %to 80 wt. %, preferably from 25 wt. %to 60 wt. %, more preferably from 30 wt. %to 50 wt. %, relative to the total weight of the composition.
- Composition according to any of claims 1 to 10, further comprising an additional polyol other than glycerin comprising 2-10 carbon atoms, preferably, the additional polyol is selected from propylene glycol, dipropylene glycol, ethylene glycol, butylene glycol, pentylene glycol, and a combination thereof.
- Composition according to claim 11, wherein the additional polyol other than glycerin is present in an amount ranging from 10 wt. %to 60 wt. %, preferably from 15 wt. %to 45 wt. %, more preferably from 18 wt. %to 35 wt. %, relative to the total weight of the composition.
- Composition according to any of claims 1 to 11, wherein the composition is anhydrous.
- Composition according to any of claims 1 to 13, comprising, in a hydrophilic phase, relative to the total weight of the composition,i) from 0.1 wt. %to 1 wt. %of boron nitride;ii) from 0.3 wt. %to 1 wt. %of acrylate/C 10-C 30 alkyl acrylate copolymer;iii) from 0.3 wt. %to 0.7 wt. %of at least one 2-acrylamido-2-methylpropanesulfonic acid (AMPS) polymer selected from acrylamido-2-methylpropanesulfonate homopolymer, ammonium polyacryloyldimethyl taurate, AMPS/hydroxyethyl acrylate copolymer, ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer, and a combination thereof;iv) from 30 wt. %to 50 wt. %of glycerin; andv) from from 18 wt. %to 35 wt. %of at least one additional polyol selected from propylene glycol, dipropylene glycol, ethylene glycol, butylene glycol, pentylene glycol, and a combination thereof.
- A cosmetic process for brightening or toning the skin, comprising applying the composition according to any of claims 1 to 14 to the skin.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2022/091214 WO2023212931A1 (en) | 2022-05-06 | 2022-05-06 | Composition for brightening or toning the skin |
| CN202280095762.7A CN119156198A (en) | 2022-05-06 | 2022-05-06 | Composition for lightening or conditioning skin |
| FR2205707A FR3136373B1 (en) | 2022-05-06 | 2022-06-14 | Composition for lightening or coloring the skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2022/091214 WO2023212931A1 (en) | 2022-05-06 | 2022-05-06 | Composition for brightening or toning the skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2023212931A1 true WO2023212931A1 (en) | 2023-11-09 |
Family
ID=88646133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2022/091214 Ceased WO2023212931A1 (en) | 2022-05-06 | 2022-05-06 | Composition for brightening or toning the skin |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN119156198A (en) |
| FR (1) | FR3136373B1 (en) |
| WO (1) | WO2023212931A1 (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070166248A1 (en) * | 2004-07-13 | 2007-07-19 | L'oreal | Aqueous photoprotective compositions comprising hydrophilic metal oxide nanopigments and polyalkylene glycols of low molecular mass |
| WO2019159726A1 (en) * | 2018-02-19 | 2019-08-22 | L'oreal | Composition comprising amps polymer |
| CN110709050A (en) * | 2017-05-12 | 2020-01-17 | 欧莱雅 | Light stable compositions made from perlite/titanium/silica composite particles |
| WO2020132855A1 (en) * | 2018-12-25 | 2020-07-02 | L'oreal | Composition for brightening or whitening keratin materials |
| US20210220235A1 (en) * | 2018-06-28 | 2021-07-22 | L'oreal | Oil-in-water composition comprising a hydrophobic polymer |
-
2022
- 2022-05-06 WO PCT/CN2022/091214 patent/WO2023212931A1/en not_active Ceased
- 2022-05-06 CN CN202280095762.7A patent/CN119156198A/en active Pending
- 2022-06-14 FR FR2205707A patent/FR3136373B1/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070166248A1 (en) * | 2004-07-13 | 2007-07-19 | L'oreal | Aqueous photoprotective compositions comprising hydrophilic metal oxide nanopigments and polyalkylene glycols of low molecular mass |
| CN110709050A (en) * | 2017-05-12 | 2020-01-17 | 欧莱雅 | Light stable compositions made from perlite/titanium/silica composite particles |
| WO2019159726A1 (en) * | 2018-02-19 | 2019-08-22 | L'oreal | Composition comprising amps polymer |
| US20210220235A1 (en) * | 2018-06-28 | 2021-07-22 | L'oreal | Oil-in-water composition comprising a hydrophobic polymer |
| WO2020132855A1 (en) * | 2018-12-25 | 2020-07-02 | L'oreal | Composition for brightening or whitening keratin materials |
Also Published As
| Publication number | Publication date |
|---|---|
| FR3136373A1 (en) | 2023-12-15 |
| FR3136373B1 (en) | 2025-08-15 |
| CN119156198A (en) | 2024-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2958630B1 (en) | Gel-type cosmetic composition | |
| US10238584B2 (en) | Gel-type cosmetic composition | |
| EP3157497B1 (en) | Solid lipstick composition having improved hardness | |
| US9078820B2 (en) | Oil-in-water emulsion containing an amphiphilic polymer and a silicone elastomer | |
| US6136305A (en) | Topical composition comprising a thickener of acrylic acid-acrylamide water-in-oil emulsion | |
| DE69612234T2 (en) | Composition in the form of an anhydrous gel with a wax-free fat phase, containing organomodified clay, expanded hollow thermoplastic particles and pyrogenic silica for topical use | |
| EP3727298B1 (en) | Coloured aqueous particle dispersion | |
| EP2579946A2 (en) | Colored aqueous cosmetic compositions | |
| EP1897534A2 (en) | Cosmetic or dermatologic compositions containing microspheres | |
| KR102498844B1 (en) | UV block cosmetic composition comprising high inorganic uv absorbers | |
| MXPA01001684A (en) | Oil-in-water emulsion comprising gellan and a particular surfactant and uses. | |
| RU2677664C2 (en) | Cosmetic method for lightening skin and/or lips | |
| KR20160012963A (en) | Cosmetic compositions with improved moisturizer and transfer resistant ability for long lasting concealing effect | |
| KR102220752B1 (en) | Cosmetic compositon comprising capsule | |
| CN113925791A (en) | Waterproof sunscreen composition and preparation method thereof | |
| WO2013190114A1 (en) | Cosmetic composition comprising non-interference scattering particles and aerogel particles, and cosmetic lightening method | |
| CN116672279A (en) | A kind of fresh and stable high multiple sunscreen lotion and preparation method thereof | |
| KR102712255B1 (en) | Water-in-oil type emulsifying cosmetic | |
| BR102014000604A2 (en) | aqueous compositions comprising polymeric particles and low clay contents | |
| WO2023212931A1 (en) | Composition for brightening or toning the skin | |
| KR102003982B1 (en) | Cosmetic Composition of Polyol-in-Oil Formulation Comprising Metal Oxide | |
| EP3689323A1 (en) | Cosmetic composition comprising organic-inorganic composite particles for blocking near infrared rays | |
| KR20190110688A (en) | Cosmetic composition of oil-in-water sunscreen reducedwhite cloudy phenomenon | |
| JP2023131115A (en) | Cosmetic bases and cosmetics containing them | |
| CN114845687B (en) | Composition for lightening or whitening keratin materials |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22940625 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202280095762.7 Country of ref document: CN |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 22940625 Country of ref document: EP Kind code of ref document: A1 |









